Mustang Bio Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Mustang Bio Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- MBIO
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001680048
Board of directors
-
Adam J. Chill · DirectorSince 2023
-
David Jin · DirectorSince 2024
-
Lindsay A. Rosenwald M.D. · DirectorSince 2016
-
Manuel Litchman M.D. · Director · President, CEO and Interim CFOSince 2023
-
Michael J. Zelefsky · DirectorSince 2023
-
Michael S. Weiss · DirectorSince 2016
-
Neil Herskowitz · DirectorSince 2023
Chief executives
Manuel Litchman M.D.
· President and CEO
Dates unknown
Board connections
3 of this board's directors also sit on 3 other boards.
- via Lindsay A. Rosenwald M.D. and Michael S. Weiss
- via Lindsay A. Rosenwald M.D. and Neil Herskowitz
- via Michael S. Weiss
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $237
- 1 purchase by 1 insider
- Sold, last 12 months
- $241
- 2 sales by 2 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Apr 24, 2026 | Manuel Litchman M.D. Director, Officer (President, CEO and Interim CFO) | Shares withheld for tax | −19 | $0.75 | $14 |
| Jan 2, 2026 | Fortress Biotech, Inc. 10% owner | Grant or award | +278,385 | — | — |
| Dec 30, 2025 | Neil Herskowitz Director | Open-market sale | −247 | $0.96 | $237 |
| Dec 30, 2025 | Adam J. Chill Director | Open-market sale | −4 | $0.95 | $4 |
| Dec 30, 2025 | David Jin Director | Open-market purchase | +247 | $0.96 | $237 |
| Sep 29, 2025 | Fortress Biotech, Inc. 10% owner | Grant or award | +59,334 | — | — |
| Apr 24, 2025 | Manuel Litchman M.D. Director, Officer (President, CEO and Interim CFO) | Shares withheld for tax | −27 | $1.24 | $33 |
| Mar 31, 2025 | Fortress Biotech, Inc. 10% owner | Grant or award | +67,806 | — | — |
| Jun 27, 2024 | Fortress Biotech, Inc. 10% owner | Grant or award | +575,191 | — | — |
| May 31, 2024 | Manuel Litchman M.D. Director, Officer (President and CEO) | Shares withheld for tax | −1,396 | $0.35 | $489 |
| Jan 2, 2024 | Fortress Biotech, Inc. 10% owner | Grant or award | +419,092 | — | — |
| Jul 5, 2023 | Michael J. Zelefsky Director | Grant or award | +7,246 | — | — |
| Jul 5, 2023 | Adam J. Chill Director | Grant or award | +7,246 | — | — |
| Jul 5, 2023 | Lindsay A. Rosenwald M.D. Director | Grant or award | +7,246 | — | — |
| Jul 5, 2023 | Michael S. Weiss Director | Grant or award | +7,246 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.